Globus Medical Inc rises on market strength and 20-day high
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 06 Jan 26
Globus Medical Inc's stock increased by 3.01%, reaching a 20-day high. This movement aligns with the positive performance of the broader market, as the Nasdaq-100 rose by 0.88% and the S&P 500 gained 0.62%.
The stock's rise is attributed to sector rotation, as investors are optimistic about the upcoming earnings report season, despite potential challenges facing corporate America. This optimism reflects a hopeful outlook for the year ahead, which may have contributed to the stock's upward movement.
The implications of this price action suggest that investors are positioning themselves favorably ahead of earnings announcements, indicating a potential for continued interest in Globus Medical Inc as the market sentiment remains positive.
Analyst Views on GMED
Wall Street analysts forecast GMED stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GMED is 101.00 USD with a low forecast of 87.00 USD and a high forecast of 114.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Analyst Rating
9 Buy
4 Hold
0 Sell
Moderate Buy
Current: 91.830
Low
87.00
Averages
101.00
High
114.00
Current: 91.830
Low
87.00
Averages
101.00
High
114.00
About GMED
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery techniques. It includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
